About us

From strategic direction to implementation, our multi-disciplinary team provides the tailored end-to-end support you need across the whole product life cycle to reach successful Regulatory Affairs and Market Access outcomes.

The board

Anita Falezza

CEO & FOUNDER

Anita founded Regulatory Pharma Net in 1999, leveraging over a decade of pharmaceutical industry experience in C-Suite roles. Her expertise covers consulting and strategic coordination of Drug Development and Regulatory Affairs projects on a global scale. She has extensive experience working with regulatory authorities, excelling in the management of Innovative, Anticancer, Biological and Biotechnological Products, and Advanced Therapies. Her in-depth industry knowledge makes her a distinguished leader in the field.

Anita Falezza

CEO & FOUNDER

Isabella Barbieri

Regulatory Affairs Director

Isabella began her career at Regulatory Pharma Net more than 20 years ago. She gained invaluable experience and deep insights into the ever-evolving regulatory landscape. Throughout her career, Isabella has demonstrated exceptional expertise and strategic vision, ensuring compliance and alignment of all matters related to Regulatory Affairs and Promotional Activities.
Under her leadership, the RPN Regulatory Affairs department thrives, safeguarding the company's operations and driving strategic success.

Isabella Barbieri

Regulatory Affairs Director

Lucia Piampiani

Market Access Director

Lucia brings over 20 years of experience in integrated Regulatory and Market Access solutions for pharmaceutical companies. Her extensive experience in Early Access and Pricing & Reimbursement processes, including negotiations with authorities, enables her to anticipate potential issues and build effective strategies that maximize product value within the EU. She played a leading role in numerous EU Market Access projects, working with SMEs to bring innovative products (including Orphan Drugs and ATMPs) to market. Her well-established network of partners in EU for pan-EU projects and close collaboration with RA and MA teams ensure a smooth launch across the EU.

Lucia Piampiani

Market Access Director

Elisabetta Radice

Organization & HR Director

Elisabetta joined Regulatory Pharma Net in 2019, bringing over 15 years of expertise in human resources, including talent acquisition, training, and resource empowerment. She cultivated a thriving organizational culture and aligned HR practices with the company’s strategic goals, fostering a positive and productive work environment.
Elisabetta holds a degree in International Political Science and several Master courses in Human Resources Management and Organizational Behavior.
Her global perspective and HR expertise make her a key business leader who understands the critical role of human capital in driving success.

Elisabetta Radice

Organization & HR Director

Giovanni Zampano

International RA Director

Giovanni brings over 15 years of experience in International Regulatory Affairs, specializing in late development, new Marketing Authorization Applications, and global life-cycle management. Driven by a deep passion for life sciences and staying ahead of the ever-evolving regulatory landscape, Giovanni excels in coordinating complex, multi-stakeholder projects. He has a successful track record of securing market authorizations (incl. advanced therapies) while ensuring top compliance. His forward-thinking and proactive approach enables him to manage potential risks early and capitalize on emerging opportunities, making him a vital asset in the regulatory field.

Giovanni Zampano

International RA Director

Our team

Our dedicated highly-qualified people are there to support you in every step of your process.

Our values

Dedication & Commitment

Introducing new healthcare therapies, products & treatments benefits us allour clients and the global population. The whole product life cycle is complex, detailed and time intensive.

To make it happen, navigating the different stages and successfully handling the complexity requires dedication and commitment to ensure every detail, every step and every process is diligently carried out.
As individuals and as a company we have a strong focus on client care and we’re committed to delivering the best possible result in every situation.

Integrity

We operate in a critical sector that directly impacts the health of the global population. This makes it essential that we do the right thing at all times, apply the highest ethical standards, and be accountable for our actions.

We’re transparent, honest, and always provide unbiased advice and direction. Setting the highest standards of behaviour allows us to build trust with our clients and the organisations we interact and deal with to achieve the outcomes we strive for.

Dynamism

The global healthcare sector is complex, intricate and continuously evolving across international markets.
We support our clients by providing the specific expertise needed to problem solve and perform different tasks in the different specialisms required. All whilst dealing with different local market demands.

This constant change, from strategic advice to operational excellence, under different legal systems, requires us to stay ahead of the curve and to work in an agile and dynamic way.

Collaboration

To help our clients succeed, we support them where they need it most. To do this effectively, we work together, plugging skill, experience and resource gaps to form a partnership that creates synergy.

We listen to their needs and understand their challenges to build a high-performing team and structure that compliments theirs sharing insight, knowledge, and expertise. Together every step of the way, we agree objectives, plan, execute and measure outcomes so we succeed together.

Incisive Thinking

Our clients look to us to help them when they face the challenges of entering new markets.

To be successful in such a high value sector they need a partner with the necessary expertise and knowledge to bring insights, devise strategies and provide clear intelligent support, proactively and efficiently. Our years of experience, team of experts and established partnerships create an environment where we possess the incisive understanding and vision to successfully introduce new healthcare solutions without delay.

Excellence

We demonstrate excellence because of our years of individual and collective quality of service, expertise, professionalism and in-market experience.

A laser focus on client needs, and how they integrate with our own outstanding skills and specialisms builds the right support to deliver outstanding results. We focus on what matters and take pride in doing even the ordinary things extraordinarily well.

Membership

DIA

DIA is the only organization dedicated to bringing health care product development professionals together in a neutral environment to foster innovation.

Offering a comprehensive catalogue of conferences, training courses, scientific publications and education materials, DIA’s goal is to raise the level of health and well-being worldwide.

Associazione Farmaceutici Industria (AFI)

The Pharmaceutical Association of Industry (AFI) collaborates with healthcare authorities, organizes scientific events, and provides continuous training. By focusing on quality, R&D, regulation, production, and innovation, AFI enhances its members' knowledge and skills through workshops, conferences, and publications, advancing the pharmaceutical industry.

EUCOPE

EUCOPE represents over 2600 small and mid-sized biopharmaceutical companies in Europe. It advocates for effective public policy, fosters industry collaboration, and promotes healthcare innovation by improving patient outcomes through workshops, conferences, and expert updates on regulatory and market access issues, advancing pharmaceutical innovation.

ISPOR

ISPOR–The Professional Society for Health Economics and Outcomes Research is a global leader dedicated to promoting health economics and outcomes research excellence to enhance healthcare decision-making. Through its variety of resources ISPOR fosters collaboration among healthcare stakeholders to improve health outcomes and inform policy.

SIARV

SIARV (Società Italiana Attività Regolatorie, Accesso, Farmacovigilanza) focuses on regulatory affairs, market access, and pharmacovigilance in Italy. It offers continuous training, seminars, and expert updates to enhance professional skills and knowledge in the pharmaceutical sector, promoting best practices and healthcare innovation.

ASSOBIOTECH FEDERCHIMICA

Assobiotec Federchimica, the Italian Association for Biotechnologies, supports biotech companies, promotes sector knowledge, and fosters networking. It engages in policy advocacy, industry analysis, and public communication to advance biotech innovation in healthcare, agriculture, and the environment.

Certifications